Age-specific seroprevalence of poliomyelitis, diphtheria and tetanus antibodies in Spain

Epidemiology and Infection

Volumn 129, Issue 3, 2002, Pages 535-541

  Pachon I ^a   Amela, C ^a   De Ory, F ^b  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA VACCINE; ORAL POLIOMYELITIS VACCINE; TETANUS ANTIBODY; TETANUS TOXOID; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE; ANTIBODY DETECTION; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DIPHTHERIA; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GROUPS BY AGE; HEALTH CENTER; HUMAN; IMMUNITY; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; PHLEBOTOMY; POLIOMYELITIS; POLIOMYELITIS VIRUS; POPULATION RESEARCH; REVIEW; RURAL AREA; SEROEPIDEMIOLOGY; SEROPREVALENCE; SPAIN; TETANUS; URBAN AREA; VACCINATION; VIRUS TYPING;

EID: 0036973445     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0950268802007781     Document Type: Review

References (30)

1. Vigilancia de la Poliomielitis en España. Bol Epidemiol Semanal. España 1989; No. 1833: 113-4.
2. Pizarro A, Pachón I. Situación actual de tétanos y tos ferina. Bol Epidemiol Semanal España 1998; 6: 300-3.
3. Rabinovich NR, Orenstein WA. Overview. Epidemiol Rev 1999; 21: 1-6.
4. Amela C, Pachón I. Estudio seroepidemiológico: situación de las enfermedades vacunables en España. Instituto de Salud Carlos III, Madrid, 2000: 35.
5. II Encuesta de Serovigilancia de la Comunidad Autónoma de Madrid. Documento Técnico de Salud Pública No. 29. Comunidad de Madrid, 1995.
6. Levy PS, Lemeshow S. Sampling of populations: methods and applications. New York: Wiley-Interscience, 1995: 212-43.
7. Cochran WG. Sampling techniques, 3rd ed. New York: Wiley, 1977: 309-58.
8. Kish L. Survey sampling. New York: Wiley-Interscience, 1995: 148-78.
9. Galazka AM. Tetanus: the immunological basis for immunization. Geneva: World Health Organization, 1993. WHO/EPI/GEN/93.13: 5.
10. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual, Release 7.0. Research Triangle Park, NC: Research Triangle Institute, 1996: 3-50.
11. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988; 10: 212-41.
12. de Melker HE, Conyn-Van Spaendonck MAE. Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiol Infect 1998; 121: 637-43.
13. Svensson A, Böttiger M, Gustavsson O. Immunity in the Swedish population: diphtheria, tetanus and poliomyelitis. Int J Epidmiol 1998; 27: 909-15.
14. Halsey NA, de Quadros CA. Avances Recientes en inmunización. Una revisión bibliográfica. Washington: Organización Panamericana de la Salud, 1983. Pub. Científica No. 451: 18-28.
15. Chen RT, Hausinger S, Dajani AS, et al. Seroprevalence of antibody against poliovirus in Inner-city preschool children. Implications for vaccination policy in the United States. JAMA 1996; 276: 1639-45.
16. Grotto I, Handsher R, Gdalevich M, et al. Decline in immunity to polio among young adults. Vaccine 2000; 19: 4162-6.
17. Böttiger M. Polio immunity to killed vaccine: an 18-year follow-up. Vaccine 1990; 8: 443-5.
18. Triassi M, Ribera G, Barrufo L, Barbone S, Medda E, Grandolfo ME. Persistence of immunity to poliomyelitis among a southern population that received four doses of OPV 5 to over 15 years before. Eur J Epidemiol 1996; 12: 5-8.
19. Mortimer EA, Wharton M. Diphtheria toxoid. In: Plotkin SA, Orenstein WA, eds. Vaccines, 3rd ed. Philadelphia: Saunders, 1999: 140-57.
20. Wassilak SG, Orenstein WA, Sytter SW. Tetanus toxoid. In: Plotkin SA, Orenstein WA, eds. Vaccines, 3rd ed. Philadelphia: Saunders, 1999: 441-74.
21. Böttiger M, Gustavsson O, Svensson A. Immunity to tetanus, diphtheria and poliomyelitis in the adult population of Sweden in 1991. Int J Epidemiol 1998; 27: 916-25.
22. Anderson RM, May RM. Infectious diseases of humans: dynamics and control, 2nd ed. New York: Oxford University Press, 1991: 87-90.
23. Plan de actuaciones necesarias para la consecución del certificado de erradicación de la poliomielitis. Bol Epidemiol Semanal España 1997; 5: 125-8.
24. Pachón I, Sanz MC. Certificación de la erradicación de la poliomielitis. Sistema de vigilancia de parálisis flácida aguda. Bol Epidemiol Semanal España 1999; 7: 189-92.
25. Galazka AM. Diphtheria: the immunological basis for immunization. Geneva: World Health Organization, 1993. WHO/EPI/GEN/93.12: 2-3.
26. Salleras L, Vidal J, Plans P, et al. Bajo grado de protección inmunitaria frente a la difteria en la población adulta de Cataluña. Med Clin 1998; 111: 692-5.
27. García O, Dal-Re R, García de Lomas J, Aguilar L. Low prevalence of diphtheria immunity in the Spanish population: results of a cross-sectional study. Vaccine 1999; 17: 1978-82.
28. Gasparini R, Pozzi T, Fragapane E, et al. Immunity to diphtheria in Siena. Epidemiol Infect 1997; 119: 203-8.
29. Souliou E, Kyriazopoulou V, Diza E, Hatzistylianou M, Frantzilou F. Serological survey on the immunity to diphtheria of the northern Greek population. Eur J Epidemiol 1997; 13: 535-9.
30. Dittmann S. Epidemic diphtheria in the newly independent states of the former USSR - situation and lessons learned. Biologicals 1997; 25: 179-86.